Cell Source, Inc.
CLCS
$0.25
-$0.02-7.41%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.23M | -5.15M | -4.91M | -5.32M | -5.61M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 242.60K | 175.20K | 246.40K | 380.60K | 459.20K |
| Total Other Non-Cash Items | 429.10K | 281.50K | 300.30K | 374.30K | 395.40K |
| Change in Net Operating Assets | 1.90M | 2.40M | 2.15M | 2.22M | 2.41M |
| Cash from Operations | -2.66M | -2.30M | -2.21M | -2.35M | -2.35M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 836.10K | 1.13M | 1.55M | 1.63M | 2.48M |
| Total Debt Repaid | -149.00K | -312.00K | -299.50K | -279.50K | -191.50K |
| Issuance of Common Stock | 415.60K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 1.58M | 1.55M | 824.90K | 799.90K | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.68M | 2.37M | 2.08M | 2.15M | 2.29M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.30K | 68.50K | -133.00K | -200.50K | -63.40K |